• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似视神经鞘脑膜瘤分次放疗的长期疗效。

Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma.

机构信息

40 Temple Street/Suite 5-B, New Haven, CT 06510, USA.

出版信息

Br J Ophthalmol. 2010 May;94(5):559-63. doi: 10.1136/bjo.2009.167346. Epub 2009 Dec 3.

DOI:10.1136/bjo.2009.167346
PMID:19965820
Abstract

BACKGROUND/AIMS To review the long-term results of treatment of optic nerve sheath meningiomas (ONSMs) with conformal radiotherapy. METHODS Eleven patients with presumed ONSM were treated with fractionated conformal radiotherapy using 45-54 Gy in 25-30 fractions and followed for more than 5 years. Affected eye visual acuity in logMAR notation, colour vision, threshold perimetry, mean deviation (dB) and imaging were studied before and after treatment. ANALYSIS Included adverse effects of treatment and the frequency of affected eye maintained or improved vision. RESULTS There were nine women and two men with a mean age of 45.3. Vision or field loss was the most common presentation. All had abnormal MR imaging. The follow-up period after radiotherapy was 61-156 months (mean 89.6). Visual acuity was unchanged or improved in 10 patients (91%). The average difference between pretreatment and final logMAR visual acuity was 0.08, while the average difference in visual-field mean deviation was -4.63 dB. The radiographic appearance of the tumours was stable in size in nine patients and decreased in two. No major side effects from radiation were seen. CONCLUSIONS Vision, MRI and complication outcomes are favourable for using fractionated conformal radiotherapy for ONSM.

摘要

背景/目的:回顾使用适形放疗治疗视神经鞘脑膜瘤(ONSM)的长期结果。

方法

11 例疑似 ONSM 患者接受了 45-54 Gy 分 25-30 次分割的分次适形放疗,并随访超过 5 年。在治疗前后研究了受影响眼的视力(以 logMAR 记法表示)、色觉、阈值视野检查、平均偏差(dB)和影像学。

分析

包括治疗的不良反应以及受影响眼视力保持或改善的频率。

结果

有 9 名女性和 2 名男性,平均年龄为 45.3 岁。视力或视野丧失是最常见的表现。所有患者均有异常的 MRI 表现。放疗后随访时间为 61-156 个月(平均 89.6)。10 例患者的视力不变或改善(91%)。治疗前和最终 logMAR 视力的平均差异为 0.08,而视野平均偏差的平均差异为-4.63 dB。9 例患者肿瘤的影像学表现大小稳定,2 例减小。未观察到明显的放射性副作用。

结论

对于 ONSM,使用分次适形放疗在视力、MRI 和并发症结果方面是有利的。

相似文献

1
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma.疑似视神经鞘脑膜瘤分次放疗的长期疗效。
Br J Ophthalmol. 2010 May;94(5):559-63. doi: 10.1136/bjo.2009.167346. Epub 2009 Dec 3.
2
Standard-fractionated radiotherapy for optic nerve sheath meningioma: visual outcome is predicted by mean eye dose.标准分割放疗治疗视神经鞘脑膜瘤:平均眼剂量可预测视力结果。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1268-77. doi: 10.1016/j.ijrobp.2011.04.010. Epub 2011 Jun 2.
3
Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.视神经鞘膜瘤患者接受适形放疗后的视觉效果和肿瘤控制情况。
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1166-72. doi: 10.1016/j.ijrobp.2008.12.056. Epub 2009 May 4.
4
Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study.原发性放射治疗进展性视神经鞘脑膜瘤:一项长期随访研究。
Br J Ophthalmol. 2010 May;94(5):564-8. doi: 10.1136/bjo.2009.166793.
5
Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma.分次立体定向放射治疗视神经鞘脑膜瘤。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):773-8. doi: 10.1016/j.ijrobp.2010.11.018. Epub 2011 Feb 6.
6
[Early symptoms and findings in optic nerve meningiomas].[视神经脑膜瘤的早期症状与发现]
Klin Monbl Augenheilkd. 2009 Nov;226(11):869-74. doi: 10.1055/s-0028-1109872. Epub 2009 Nov 13.
7
[Fractionated stereotactic radiotherapy for optic nerve sheath meningioma: eight cases].[视神经鞘膜瘤的分次立体定向放射治疗:8例]
Neurochirurgie. 2007 Nov;53(5):333-8. doi: 10.1016/j.neuchi.2007.07.031. Epub 2007 Aug 20.
8
Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma.原发性视神经鞘膜瘤分次立体定向放射治疗后早期视力改善情况
Radiother Oncol. 2004 Aug;72(2):169-74. doi: 10.1016/j.radonc.2004.04.008.
9
Fractionated stereotactic conformal radiotherapy for optic nerve sheath meningiomas.分次立体定向适形放疗视神经鞘脑膜瘤。
Clin Oncol (R Coll Radiol). 2012 Oct;24(8):e106-12. doi: 10.1016/j.clon.2012.03.015. Epub 2012 May 22.
10
Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery.分次立体定向放射治疗视神经鞘膜瘤:30例患者33条视神经的初步观察,并与既往有无手术的观察结果进行历史对照。
Neurosurgery. 2002 Oct;51(4):890-902; discussion 903-4. doi: 10.1097/00006123-200210000-00007.

引用本文的文献

1
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.脑膜瘤:脑膜瘤国际联合会关于临床医生、研究人员和患者的科学进展和治疗模式的共识综述。
Neuro Oncol. 2024 Oct 3;26(10):1742-1780. doi: 10.1093/neuonc/noae082.
2
The treatment efficacy of radiotherapy for optic nerve sheath meningioma.放疗治疗视神经鞘脑膜瘤的疗效。
Eye (Lond). 2024 Jan;38(1):89-94. doi: 10.1038/s41433-023-02640-7. Epub 2023 Jun 22.
3
Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas.
作为颅内脑膜瘤主要治疗手段的分次放射治疗的疗效及反应预测因素
Clin Transl Radiat Oncol. 2023 Apr 24;41:100631. doi: 10.1016/j.ctro.2023.100631. eCollection 2023 Jul.
4
Neurocognitive considerations in the treatment of meningioma with radiation therapy: applications for quantitative neuroimaging and precision radiation medicine.神经认知在脑膜瘤放射治疗中的考虑因素:定量神经影像学和精准放射医学的应用。
J Neurooncol. 2023 Jan;161(2):277-286. doi: 10.1007/s11060-022-04175-5. Epub 2022 Dec 26.
5
68Ga-DOTATOC-PET/MRI-A Secure One-Stop Shop Imaging Tool for Robotic Radiosurgery Treatment Planning in Patients with Optic Nerve Sheath Meningioma.68Ga-DOTATOC-PET/MRI——用于视神经鞘膜瘤患者机器人放射外科治疗计划的一站式安全成像工具
Cancers (Basel). 2021 Jul 1;13(13):3305. doi: 10.3390/cancers13133305.
6
Primary and Secondary Optic Nerve Sheath Meningioma.原发性和继发性视神经鞘膜脑膜瘤。
J Neurol Surg B Skull Base. 2021 Feb;82(1):27-71. doi: 10.1055/s-0041-1723801. Epub 2021 Feb 18.
7
Prognostic Factors for Functional Outcome of Patients with Optic Nerve Sheath Meningiomas Treated with Stereotactic Radiotherapy-Evaluation of Own and Meta-Analysis of Published Data.立体定向放射治疗视神经鞘膜瘤患者功能预后的预测因素——自身研究及已发表数据的荟萃分析评估
Cancers (Basel). 2021 Jan 29;13(3):522. doi: 10.3390/cancers13030522.
8
Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.调强放射治疗对视神经鞘膜瘤的疗效
Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2297-2306. doi: 10.1007/s00417-019-04424-w. Epub 2019 Aug 3.
9
Optic nerve sheath meningiomas: prevalence, impact, and management strategies.视神经鞘膜瘤:患病率、影响及管理策略。
Eye Brain. 2018 Oct 24;10:85-99. doi: 10.2147/EB.S144345. eCollection 2018.
10
Optic Nerve Sheath Meningioma: Preliminary Analysis of the Role of Radiation Therapy.视神经鞘膜瘤:放射治疗作用的初步分析
Brain Tumor Res Treat. 2018 Apr;6(1):8-12. doi: 10.14791/btrt.2018.6.e2. Epub 2018 Apr 2.